SUFU and rhabdomyosarcoma: Particularly, researchers revealed that Sufu−/− animals developed medulloblastoma and rhabdomyosarcoma in conjunction with p53 loss and the following hedgehog antagonist treatment did not block growth of tumors arising from Sufu inactivation [7].